Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mucosal immunization with DNA-liposome complexes

L S Klavinskis1, L Gao, C Barnfield

  • 1Department of Immunology, Guy's Hospital Medical School, United Medical School of Guy's Hospital, London, UK.

Vaccine
|June 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypotonicity promotes epithelial gap closure by lamellipodial protrusion.

Progress in biophysics and molecular biology·2017
Same author

Effect of Preoperative Growth Status on Clinical Outcomes After Living-Donor Liver Transplantation in Infants.

Transplantation proceedings·2017
Same author

[Diagnostic values of BRAF(V600E) mutation analysis and Bethesda system for reporting thyroid cytopathology in thyroid nodules with TIRADS 4 and 5].

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery·2017
Same author

Targeting histone-acetyltransferase Tat-interactive protein 60 inhibits intestinal allergy.

Allergy·2017
Same author

Optical bistability in graphene-wrapped dielectric nanowires.

Optics express·2017
Same author

Genital HPV infection among heterosexual and homosexual male attendees of sexually transmitted diseases clinic in Beijing, China.

Epidemiology and infection·2017
Same journal

Retraction notice to "Effectiveness of prescription-based influenza vaccination services among older adults in Binzhou, China: A cluster-randomized controlled trial" [Vaccine 82 (2026) 128588].

Vaccine·2026
Same journal

Barriers and facilitators to COVID-19 vaccination programme implementation in Ireland: a qualitative study of implementation stakeholders using CFIR.

Vaccine·2026
Same journal

Immunogenicity and safety of a SARS-CoV-2 recombinant vaccine S-268024 booster vaccination versus NVX-CoV2373: Interim results from a phase 3, multicenter, randomized, observer-blind, active-controlled study.

Vaccine·2026
Same journal

Safety and immunogenicity of a reduced, homologous booster dose of the BNT162b2 mRNA COVID-19 vaccine: a single blind, randomized, non-inferiority follow-up trial.

Vaccine·2026
Same journal

Vaccination policies for healthcare personnel in Europe, 2026.

Vaccine·2026
Same journal

A historical overview of the anti-vaccine movement and its public health implications.

Vaccine·2026
See all related articles

DNA immunization via the nasal passage can stimulate systemic and mucosal immunity. This approach, using liposome-encapsulated DNA, shows promise for developing vaccines against mucosal viruses like HIV.

Area of Science:

  • Immunology
  • Vaccinology
  • Molecular Biology

Background:

  • Mucosal surfaces are primary sites for viral transmission, necessitating vaccines that induce immunity at these locations.
  • Current vaccine strategies may require enhancement to effectively stimulate immune responses within mucosal tissues.
  • Targeting antigen-presenting cells in mucosal-associated lymphoid tissues is crucial for optimal mucosal immunity.

Purpose of the Study:

  • To evaluate the feasibility of nasal DNA immunization for stimulating systemic and mucosal immune responses.
  • To investigate the role of liposome formulation in enhancing DNA vaccine delivery and immunogenicity.
  • To assess the induction of humoral and cellular immunity following nasal DNA immunization.

Main Methods:

  • DNA immunization using firefly luciferase as a model antigen delivered via the nasal mucosa.

Related Experiment Videos

  • Formulation of DNA with cationic lipids in liposomes to enhance expression in nasal tissue.
  • Analysis of systemic immune responses (serum antibodies) and mucosal immune responses (vaginal IgA).
  • Assessment of cellular immunity, including T-cell proliferation and cytotoxic T-lymphocyte activity, in lymphoid tissues.

    • Main Results:

    • Liposome-encapsulated DNA significantly enhanced luciferase expression in nasal tissue compared to unencapsulated DNA.
    • Nasal DNA immunization induced a detectable humoral immune response in both serum and vaginal fluids.
    • A significant proliferative and cytotoxic T-lymphocyte response was observed in the spleen and iliac lymph nodes.

    Conclusions:

    • Nasal DNA immunization is a feasible strategy for inducing both systemic and mucosal immunity.
    • Liposome formulation enhances the immunogenicity of DNA vaccines delivered via the nasal route.
    • This approach holds potential for developing vaccines against viruses transmitted through mucosal surfaces, such as HIV.